The incidence of nontyphoidal Salmonella (NTS) infections is rising worldwide and several outbreaks have been reported recently. Immunosuppressed patients are particularly vulnerable to NTS infections. We retrospectively examined the clinical features and outcomes of 18 recipients of hematopoietic SCT (HSCT) who were diagnosed with NTS infection at our institution during a 15-year period. Bacteremia was the most common presenting feature and occurred in 67% of cases. Diarrhea was absent in one-third of cases. Among 12 recipients of allogeneic HSCT, 8 presented with bacteremia and only 6 had diarrhea. A total of 9 of these 12 patients had chronic GVHD. Metastatic disease was distinctly rare and occurred in only two patients, whereas one patient died of NTS sepsis. Food safety practices to prevent NTS infection are important in HSCT recipients, particularly for those who have chronic GVHD after allogeneic HSCT.
Introduction
Recent foodborne outbreaks of nontyphoidal Salmonella (NTS) infections in the United States highlight the risk that NTS infections pose to the general population. 1 The incidence of such infections appears to be increasing in the United States and elsewhere. 1, 2 Patients who are immunocompromised represent a population that is particularly susceptible to NTS infection. These include patients with HIV infection, autoimmune disease, organ transplants and cancer. 3 An outbreak of NTS infection among attendees of the United States Transplant Games in 2002 illustrates the vulnerability of transplant recipients to NTS. 4 NTS cause a spectrum of illnesses including diarrheal disease, invasive bacteremic illness, focal suppurative/ metastatic infection and asymptomatic carriage in stool. 3 Immunocompromised patients are more likely to present with primary bacteremic illness in the absence of diarrheal disease, thereby making the diagnosis difficult. 5 Moreover, NTS infection presenting as diarrheal illness may mimic GVHD in the setting of allogeneic hematopoietic SCT (HSCT). 6 With the exception of few case reports, limited data exist with regard to NTS infections in patients who have undergone HSCT. [6] [7] [8] We retrospectively analyzed the clinical and microbiological features of NTS infection among patients with hematological disease and recipients of HSCT who presented to our institution during a 15-year period.
Patients and methods
This retrospective study was approved by the institutional review board of the City of Hope Medical Center. Medical records of patients who presented to our institution and had NTS isolated from any site during a 15-year period from 1994 to 2009 were reviewed. From these records, HSCT recipients were identified and are the subject of this report.
Results
The clinical features of the patients are summarized in Table 1 . Details of individual cases are provided in Table 2. A total of 18 patients were identified. They had a median age of 41.5 years (range, 6.5-71 years) and included 13 males and 5 females. In all, 12 patients had received allogeneic HSCT and 6 had received autologous HSCT. Among the 12 recipients of allogeneic HSCT, 9 had extensive chronic GVHD. Two patients had undergone splenectomy.
Fever was a presenting symptom in 12 of 18 patients (67%). Bacteremia was present in 12 patients (67%) at presentation (8 allogeneic HSCT, 4 autologous HSCT). Diarrhea was a presenting symptom in 12 patients (67%) (6 allogeneic HSCT, 6 autologous HSCT), whereas 5 patients (28%) had diarrhea alone. Eight patients had NTS isolated from stool. Of note, among the 12 allogeneic HSCT recipients, 8 patients had bacteremia, 7 of whom had extensive chronic GVHD and diarrhea was present in 6. A total of 4 of the 12 allogeneic HSCT recipients presented with fever in the absence of diarrhea. Recurrent infection occurred in one patient. Two patients had metastatic infection (septic arthritis of knee and cellulitis); both of whom had extensive chronic GVHD. Median time from onset of symptoms to diagnosis was 7.5 days (range, 5-10 days).
There was one death from Salmonella sepsis. This occurred in a patient with extensive chronic GVHD and cirrhosis, 3 months after treatment of an initial episode of NTS gastroenteritis, at which time the patient presented with NTS bacteremia and cellulitis and died of septic shock. All other patients recovered with antibiotic therapy, which comprised of a third-generation cephalosporin or a quinolone or both. Salmonella groups D and E accounted for most of the isolated strains, whereas others included groups C, 3A and E. Serotype data were available for 14 of the 18 patients and are shown in Table 2 . Serotype enteritidis was the most common and was isolated in 6 of the 14 cases (43%). All isolates were sensitive to the empiric antibiotic (ceftazidime or quinolone) started at presentation. In all, 13 of 15 patients in whom data on treatment duration were available were treated for 14 days. (Table 2 ).
Discussion
Our results highlight the clinical presentation of NTS infections in HSCT recipients, and is the only case series of NTS infections in this population. Immunosuppressed patients are more likely to present with primary bacteremia, as was the case in our patients. Although lack of diarrhea has been reported to be a marker of underlying immunosuppression, 3, 5 in our series, diarrhea was noted in 67% of the patients overall and in 50% of the allogeneic HSCT recipients, who constitute a group with the greatest degree of immunosuppression, especially in the setting of chronic GVHD. Metastatic/focal suppurative infection occurred only in two patients and, therefore, appears to be distinctly uncommon in this patient population.
In a retrospective study of 235 adult patients with NTS bacteremia admitted to a single center in Taiwan, 11% had an underlying hematological malignancy. These authors identified immunodeficiency as the only predictor for recurrent bacteremia. A total of 14% of patients with recurrent bacteremia had an underlying hematological malignancy. 9 There are only two reported cases in the literature of focal NTS infection among recipients of allogeneic HSCT, again suggesting that focal infections are extremely rare after HSCT. In the first case, renal Salmonella enteritidis abscess developed in a patient with extensive chronic GVHD in the absence of bacteremia. 8 Another patient developed Salmonella enteritidis septic arthritis after presenting with bacteremic illness. 7 NTS has been rarely reported as a cause of diarrhea in HSCT patients. 10 NTS infection, mostly bacteremia, has been reported in recipients of heart and kidney transplants. [11] [12] [13] The recurrence rate in our case series was low at 5.5% compared with 35% reported in renal transplant recipients. 12 There was only one death attributable to Salmonella sepsis, suggesting that prompt empiric broad-spectrum antibiotic therapy in febrile HSCT patients is effective in averting mortality from NTS infection. One case of fatal NTS infection reported in literature manifested with severe diarrhea 80 days after allogeneic HSCT, thereby mimicking acute GVHD of the gut. This patient was treated for acute GVHD, with the diagnosis of NTS becoming evident only after the patients death. 6 Although antibiotic resistance is an emerging issue with both typhoidal and NTS infections, in our case series, the isolated strains were universally sensitive to quinolones and third-generation cephalosporins. Therefore, it appears that an empiric antibiotic regimen comprising of a thirdgeneration cephalosporin, quinolone or carbapenem will provide adequate coverage for NTS infection in HSCT recipients.
The precise incidence of NTS infections in HSCT patients cannot be determined from this retrospective analysis. In a large population-based Danish study of Salmonella diarrheal illness, the comorbidity-adjusted incidence rate ratio for Salmonella infection among patients with hematological malignancy compared with those without malignancy was 8.33.
14 As many immunosuppressed patients do not have diarrhea, this may be an underestimate of risk. Our institution is a referral center for HSCT performing B500 transplants per year. The majority of HSCT recipients are followed up at our center for an extended period of time. However, it is possible that we may have missed some mild cases with self-limited diarrheal illness and some patients may have been prescribed antibiotics for a febrile episode by their primary physicians, thereby precluding establishment of a diagnosis of NTS bacteremia.
Primary bacteremic presentation of NTS infection is common in recipients of allogeneic HSCT. Particular attention should be paid to food safety practices in these patients, especially if they have chronic GVHD. Episodes of diarrhea in such patients should be routinely evaluated for NTS infection, especially in those suspected to have GVHD of the gut. Fever or suspected sepsis in such patients should 
